시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
심혈관 장치 시장 분석과 예측(-2034년) : 유형, 제품, 기술, 용도, 재료 유형, 장치, 최종 사용자, 기능, 설치 유형, 형태
Cardiovascular Devices Market Analysis and Forecast to 2034: Type, Product, Technology, Application, Material Type, Device, End User, Functionality, Installation Type, Mode
상품코드 : 1711597
리서치사 : Global Insight Services
발행일 : 2025년 04월
페이지 정보 : 영문 323 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 7,047,000
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 5,750 ￦ 8,531,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 6,750 ￦ 10,014,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.


한글목차

세계의 심혈관 장치 시장은 2024년 524억 달러에서 2034년까지 943억 달러로 확대되어 CAGR 약 6.1%를 보일 것으로 예측됩니다. 페이스메이커, 스텐트, 심장 판막, 진단기 등이 포함됩니다. 심혈관 질환의 유병률의 상승, 기술의 진보, 헬스 케어 지출 증가에 견인되어 시장은 큰 성장을 이루고 있습니다.

시장 개요

심혈관 장치 시장은 다양한 부문을 특징으로 하며, 심혈관 질환 관리에 중요한 역할을 하는 치료 장비 부문이 주도하고 있습니다. 치료 장비의 장점은 심혈관 질환의 유병률 증가, 낮은 침습 치료의 진보, 노인 인구 증가에 의해 초래됩니다. 신흥 하위 부문 중에서 웨어러블 심혈관 장치가 기술의 진보와 실시간 건강 모니터링에 대한 소비자 수요에 힘입어 기세를 늘리고 있습니다. 환자의 결과를 향상시키고 건강 관리 비용을 줄일 수 있는 큰 잠재력을 제공합니다.

시장 세분화
유형 진단 장비, 치료 장비, 모니터링 장비
제품 스텐트, 심장 밸브, 심박 조율기, 제세동기, 카테터, 가이드와이어, 심장 보조 장치, 전기 생리 학적 장치
기술 낮은 침습, 비침습, 임플란트, 웨어러블
용도 관상 동맥 질환, 심부전, 부정맥, 말초 혈관 질환
재료 유형 금속, 중합체, 생물학, 복합재료
장치 이식 가능한 제세동기, 보조 인공 심장, 심장 재 동기화 치료 장비
최종 사용자 병원, 외래수술센터(ASC), 진료소, 재택치료 시설
기능 진단, 치료, 모니터링
설치 유형 고정, 휴대용
형태 침습성, 비침습성

심혈관 장치 분야에서는 진단 및 모니터링 장비가 시장에서 우세한 지위를 차지하고 있으며 치료 장비가 약간의 차이로 이어지고 있습니다. 북미가 시장 도입으로 선도하고 있는 것은 선진적인 헬스케어 인프라와 다액의 R&D 투자가 배경에 있습니다.

Medtronic, Abbott, Boston Scientific과 같은 업계 선두는 전략적 합병과 혁신적인 제품 개발을 통해 시장에서의 존재감을 높이고 있습니다. 진단 및 웨어러블 헬스 기술 등의 기술 진보가 시장 확대의 기폭제가 될 것으로 예측됩니다.

주요 동향 및 촉진요인:

심혈관 장치 시장은 의료 기술의 진보와 세계 인구의 고령화에 의해 강력한 성장을 이루고 있습니다.

또 다른 중요한 동향은 낮은 침습 수술의 대두입니다. 저침습 수술은 회복 시간의 단축과 합병증 위험의 저하에 의해 점점 선호되고 있습니다.

촉진요인으로는 라이프 스타일 요인과 평균 수명이 증가함에 따라 박차가 걸린 심혈관 질환의 유병률 상승이 포함됩니다. 이에 신흥 시장은 헬스케어 인프라가 개선되어 심혈관 건강에 대한 의식이 높아짐에 따라 유리한 기회를 가져오고 있습니다.

억제요인과 도전:

심혈관 장치 시장은 몇 가지 심각한 억제요인과 문제에 직면하고 있습니다. 또한, 심혈관 장치의 가격이 높기 때문에 저소득층이 이용하기 쉬운 환경이 제한되어 시장에 침투가 방해되고 있습니다. 사이버 보안 위협에 대한 우려도 높아지고 있습니다. 기술 발전 속도가 빠르기 때문에 R&D에 대한 지속적인 투자가 필요하며 중소기업의 경우 재정적인 부담이 될 수 있습니다.

목차

제1장 심혈관 장치 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 심혈관 장치 시장 전망

제5장 심혈관 장치 시장 전략

제6장 심혈관 장치 시장 규모

제7장 심혈관 장치 시장 : 유형별

제8장 심혈관 장치 시장 : 제품별

제9장 심혈관 장치 시장 : 기술별

제10장 심혈관 장치 시장 : 용도별

제11장 심혈관 장치 시장 : 재료 유형별

제12장 심혈관 장치 시장 : 장치별

제13장 심혈관 장치 시장 : 최종 사용자별

제14장 심혈관 장치 시장 : 기능별

제15장 심혈관 장치 시장 : 설치 유형별

제16장 심혈관 장치 시장 : 형태별

제17장 심혈관 장치 시장 : 지역별

제18장 경쟁 구도

제19장 기업 프로파일

JHS
영문 목차

영문목차

Cardiovascular Devices Market is anticipated to expand from $52.4 billion in 2024 to $94.3 billion by 2034, growing at a CAGR of approximately 6.1%. The market encompasses medical devices used in diagnosing and treating heart and blood vessel conditions. This includes pacemakers, stents, heart valves, and diagnostic machines. Driven by the rising prevalence of cardiovascular diseases, technological advancements, and increasing healthcare expenditure, the market is witnessing significant growth. Innovations in minimally invasive procedures and the integration of AI for predictive analytics are enhancing patient outcomes, presenting lucrative opportunities for stakeholders.

Market Overview

The Cardiovascular Devices Market is characterized by diverse segments, with the therapeutic devices segment leading due to its critical role in managing cardiovascular diseases. This segment includes pacemakers, stents, and defibrillators, which are essential for treating heart conditions. The dominance of therapeutic devices is driven by the increasing prevalence of cardiovascular diseases, advancements in minimally invasive procedures, and the growing geriatric population. Diagnostic devices, such as electrocardiograms and imaging systems, follow closely, reflecting the emphasis on early detection and monitoring. Among emerging sub-segments, wearable cardiovascular devices are gaining momentum, fueled by technological advancements and consumer demand for real-time health monitoring. These devices, often integrated with AI and IoT technologies, offer significant potential to enhance patient outcomes and reduce healthcare costs. The integration of telemedicine with cardiovascular care is also poised to transform the market, providing remote monitoring solutions and expanding access to healthcare services.

Market Segmentation
TypeDiagnostic Devices, Therapeutic Devices, Monitoring Devices
ProductStents, Heart Valves, Pacemakers, Defibrillators, Catheters, Guidewires, Cardiac Assist Devices, Electrophysiology Devices
TechnologyMinimally Invasive, Non-Invasive, Implantable, Wearable
ApplicationCoronary Artery Disease, Heart Failure, Arrhythmia, Peripheral Vascular Disease
Material TypeMetal, Polymer, Biological, Composite
DeviceImplantable Cardioverter Defibrillators, Ventricular Assist Devices, Cardiac Resynchronization Therapy Devices
End UserHospitals, Ambulatory Surgical Centers, Clinics, Homecare Settings
FunctionalityDiagnostic, Therapeutic, Monitoring
Installation TypeFixed, Portable
ModeInvasive, Non-Invasive

In the realm of cardiovascular devices, diagnostic and monitoring devices hold the preeminent market position, closely followed by therapeutic devices. This hierarchy is propelled by the rising prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures. The North American region leads in market adoption, attributed to advanced healthcare infrastructure and significant R&D investments. Meanwhile, the Asia-Pacific region is witnessing accelerated growth due to increasing healthcare expenditure and a burgeoning patient population.

Prominent industry players, including Medtronic, Abbott, and Boston Scientific, are enhancing their market presence through strategic mergers and innovative product developments. Regulatory frameworks, particularly in North America and Europe, significantly impact market dynamics, ensuring product safety and efficacy. The future outlook is favorable, with technological advancements such as AI-driven diagnostics and wearable health tech anticipated to catalyze market expansion. Nonetheless, challenges such as stringent regulatory requirements and high device costs persist, yet the ongoing evolution of telemedicine and personalized medicine presents substantial opportunities for growth.

Recent Developments:

In the dynamic landscape of the Cardiovascular Devices Market, recent months have witnessed significant developments. Medtronic has announced the launch of a groundbreaking cardiac monitoring device, which promises to enhance patient outcomes through advanced analytics and real-time data monitoring. Meanwhile, Boston Scientific has entered into a strategic partnership with a leading AI firm to integrate machine learning capabilities into their cardiovascular diagnostics, aiming to improve accuracy and predictive outcomes. Abbott Laboratories has expanded its portfolio with the acquisition of a cutting-edge stent technology company, enhancing its market position in minimally invasive cardiovascular treatments. In regulatory news, the FDA has issued new guidelines aimed at accelerating the approval process for innovative cardiovascular devices, a move expected to stimulate further innovation and market growth. Finally, Johnson & Johnson has reported a substantial increase in its cardiovascular device sales, driven by the successful launch of its latest heart valve replacement technology, underscoring the robust demand in this sector.

Key Trends and Drivers:

The cardiovascular devices market is experiencing robust growth, propelled by advancements in medical technology and an aging global population. Key trends include the integration of artificial intelligence and machine learning in device diagnostics and monitoring. These technologies enhance accuracy and predictive capabilities, leading to better patient outcomes and streamlined healthcare processes.

Another significant trend is the rise of minimally invasive procedures, which are increasingly preferred due to their reduced recovery times and lower risk of complications. This shift is driving demand for innovative devices that support such procedures. The market is also witnessing an increased focus on personalized medicine, with devices being tailored to individual patient needs, enhancing treatment effectiveness.

Drivers include the rising prevalence of cardiovascular diseases, spurred by lifestyle factors and increased life expectancy. Governments and healthcare providers are prioritizing cardiovascular health, leading to higher investments in research and development. Furthermore, emerging markets are presenting lucrative opportunities as healthcare infrastructure improves and awareness of cardiovascular health grows. Companies that can innovate and adapt to these evolving trends are well-positioned to capture significant market share.

Restraints and Challenges:

The cardiovascular devices market is confronted with several significant restraints and challenges. A primary challenge is the stringent regulatory landscape, which prolongs approval processes and increases costs for manufacturers. This can delay the introduction of innovative devices to the market. Furthermore, the high cost of cardiovascular devices limits their accessibility in low-income regions, restricting market penetration. There is also a growing concern about cybersecurity threats, as many devices are now connected to networks, posing risks to patient data and safety. Additionally, the market faces intense competition, which can lead to price wars and reduced profit margins. Finally, the rapid pace of technological advancements necessitates continuous investment in research and development, which can be financially burdensome for smaller companies. These challenges collectively hinder the market's growth and demand strategic solutions to overcome.

Key Companies:

Biotronik, Terumo Corporation, Liva Nova, Micro Port Scientific Corporation, Cardiovascular Systems, Inari Medical, Abiomed, Shockwave Medical, Penumbra, Merit Medical Systems, Angio Dynamics, Corindus Vascular Robotics, Endologix, Atri Cure, Cryo Life, Inspire MD, Orbus Neich, Stentys, Reva Medical, Biostage

Sources:

World Health Organization (WHO), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), American Heart Association (AHA), British Heart Foundation, European Society of Cardiology (ESC), World Heart Federation (WHF), Centers for Disease Control and Prevention (CDC), National Heart, Lung, and Blood Institute (NHLBI), International Society for Heart and Lung Transplantation (ISHLT), Harvard T.H. Chan School of Public Health, Johns Hopkins University School of Medicine, Mayo Clinic, Cleveland Clinic, American College of Cardiology (ACC) Annual Scientific Session & Expo, European Society of Cardiology Congress, Transcatheter Cardiovascular Therapeutics (TCT) Conference, American Heart Association Scientific Sessions, Cardiovascular Research Technologies (CRT) Conference, MedTech Europe

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cardiovascular Devices Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Cardiovascular Devices Market Outlook

5: Cardiovascular Devices Market Strategy

6: Cardiovascular Devices Market Size

7: Cardiovascular Devices Market, by Type

8: Cardiovascular Devices Market, by Product

9: Cardiovascular Devices Market, by Technology

10: Cardiovascular Devices Market, by Application

11: Cardiovascular Devices Market, by Material Type

12: Cardiovascular Devices Market, by Device

13: Cardiovascular Devices Market, by End User

14: Cardiovascular Devices Market, by Functionality

15: Cardiovascular Devices Market, by Installation Type

16: Cardiovascular Devices Market, by Mode

17: Cardiovascular Devices Market, by Region

18: Competitive Landscape

19: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기